SB
Sasha Bernatsky
Research areas: Medicine · Rheumatology · Systemic Lupus Erythematosus Research · Rheumatoid Arthritis Research and Therapies · Systemic Sclerosis and Related Diseases
0000-0002-9515-2802
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (91)
- Combination advanced therapy use and infection risks in immune-mediated inflammatory diseases Save
- Validation of International Classification of Diseases Code–Based Case Definitions of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis From Administrative Health Data Save
- Comparative Burden of COVID-19 in Adults with Rheumatic Diseases and Immunocompetent Individuals: A Population-Based Cohort Study in Quebec, Canada, 2020-2023 Save
- Biosimilar Rituximab in ANCA‐Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study Save
- Exploring Needs and Barriers to Pregnancy Counselling in Women with Systemic Lupus Erythematosus: Insights for Developing Interventional Strategies Save
- Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus Save
- Fine Particulate Matter Constituents, Ozone, and Systemic Lupus Erythematosus: A Large General‐Population Cohort Analysis With Extended Quantile g‐Computation Save
- Artificial Intelligence–Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives Save
- Diarrhoea events in offspring exposed to tumour necrosis factor inhibitors and rotavirus vaccine: a population-based cohort study Save
- Serious Infections in Offspring Exposed to Tumor Necrosis Factor Inhibitors During Pregnancy: Comparison of Timing During Pregnancy and Placental Transfer Ability Save
- Soluble SIGLEC1 as a Biomarker of Disease Activity in Idiopathic Inflammatory Myopathies Save
- A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus Save
- Patient perspectives on clinical trial participation for novel advanced therapies: a focus group study in systemic lupus erythematosus Save
- Fine particulate matter air pollution and anti-nuclear antibodies Save
- Forgotten costs of systemic lupus erythematosus: estimating indirect healthcare costs in a national prospective observational Canadian lupus cohort Save
- Reply Save
- A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases Save
- Systemic Autoimmune Rheumatic Disease Risk: Association With Long‐Term Exposure to Fine Particulate Matter Save
- Understanding Patient and Physician Perspectives Regarding Innovative Research in Rheumatoid Arthritis Save
- COVID-19 Infections Still Occur: How Do Pregnant and Non-Pregnant Individuals Compare? A Study from the Canadian Mother–Child Initiative on Drug Safety in Pregnancy (CAMCCO) Save